<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04039009</url>
  </required_header>
  <id_info>
    <org_study_id>UU-MREC-2019-9/22</org_study_id>
    <nct_id>NCT04039009</nct_id>
  </id_info>
  <brief_title>Apical Pelvic Support in Infertility Patients</brief_title>
  <official_title>Apical Pelvic Compartment Support in Infertility Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Uludag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Uludag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate apical pelvic compartment support in infertility patients at the
      time of hysteroscopy. Apical pelvic compartment evaluation for pelvic organ prolapse will be
      performed in infertility patients undergoing hysteroscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of pelvic organ prolapse in the whole population has been demonstrated several
      times in previous studies. However, pelvic floor defects in young infertility patients are
      not known. In this study, a clinical pelvic floor assessment with the pelvic organ
      quantification system will be performed in infertility patients during standard physical
      examinations or hysteroscopy.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">October 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stages of the pelvic organ prolapse</measure>
    <time_frame>2 minutes</time_frame>
    <description>Once the measurements are taken, the infertility patients are assigned to the corresponding POP-Q stage. Stage-0 is no prolapse. Stage-1 stands for the most distal portion of the prolapse is more than 1 cm above the level of the hymen. Stage-2 stands for the most distal prolapse is between 1 cm above and 1 cm below the hymen (at least one point is âˆ’1, 0, or +1). Stage-3: The most distal prolapse is more than 1 cm below the hymen but no further than 2 cm less than total vaginal length. Stage-4 stands for the complete vaginal eversion.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1100</enrollment>
  <condition>Infertility, Female</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <condition>Pelvic Floor Disorders</condition>
  <arm_group>
    <arm_group_label>Infertility patients</arm_group_label>
    <description>Infertility patients will be examined according to the pelvic organ prolapse quantification classification system during hysteroscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pelvic Organ Prolapse Quantification system</intervention_name>
    <description>The Pelvic Organ Prolapse Quantification system assessment tool measures nine anatomical points and distances in the vagina. The hymen is the reference point to which the other points are compared. The prolapsed organs are measured in centimeters to the hymen with an examination ruler.</description>
    <arm_group_label>Infertility patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population is the patients examined for female infertility.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages between 18-45

          -  Patients who cannot become pregnant despite regular sexual intercourse for more than
             one year

        Exclusion Criteria:

          -  Malignity

          -  Patients who become pregnant during infertility assessment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Patients examined for female infertility will be included in the study.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Gurkan Uncu, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>ULUDAG UNIVERSITY HOSPITAL BURSA TURKEY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adnan Orhan, M.D.</last_name>
    <phone>+905056337102</phone>
    <email>dr.adnan.orhan@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kemal Ozerkan, Prof.</last_name>
    <phone>+905056337102</phone>
    <email>ozerkan@uludag.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uludag University Hospital, Department of Obstetrics and Gynecology</name>
      <address>
        <city>Bursa</city>
        <state>Ozluce</state>
        <zip>16059</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adnan Orhan, M.D.</last_name>
      <phone>+90 505 6337102</phone>
      <email>dr.adnan.orhan@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Isil Kasapoglu, M.D</last_name>
      <phone>+905305455848</phone>
      <email>kasapogluisil@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, Spino C, Whitehead WE, Wu J, Brody DJ; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008 Sep 17;300(11):1311-6. doi: 10.1001/jama.300.11.1311.</citation>
    <PMID>18799443</PMID>
  </reference>
  <reference>
    <citation>Swift SE. The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care. Am J Obstet Gynecol. 2000 Aug;183(2):277-85.</citation>
    <PMID>10942459</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>July 28, 2019</study_first_submitted>
  <study_first_submitted_qc>July 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2019</study_first_posted>
  <last_update_submitted>July 30, 2019</last_update_submitted>
  <last_update_submitted_qc>July 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Uludag University</investigator_affiliation>
    <investigator_full_name>Adnan Orhan</investigator_full_name>
    <investigator_title>Principal Investigator. Associate professor, Obstetrician and Gynecologist</investigator_title>
  </responsible_party>
  <keyword>Pelvic organ prolapse</keyword>
  <keyword>Infertility</keyword>
  <keyword>Apical pelvic support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
    <mesh_term>Pelvic Floor Disorders</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

